This delivery order, valued at $52,288, was awarded by the Defense Health Agency of the Department of Defense to BMI to provide reagents for the IRICell 3000 under Option III of an existing contract vehicle. The firm fixed price order calls for BMI to supply the reagents to a location in South Korea between October 2022 and September 2023. No subcontractors or set aside designations were identified. The Defense Health Agency manages the military health system and conducts medical research, so the reagents are likely supporting medical testing or research activities for DOD personnel stationed in or around South Korea.